Литература о применении МАРС:

1. Mitzner S, Stange J, Klammt S, Peszynski P, Schmidt R, Nöldge-Schomburg G
   Extracorporeal detoxifikation using the Molecular Adsorbent Recirculating System for critically ill patients with liver failure
   J Am Soc Nephrol 12: S75-282, 2001
2. Novelli G, Rossi M, Pretagostini R, Poli L, Peritore D, Berloco P, Di Nicuolo A, Iappelli M, Cortesini R
   Use of MARS in the Treatment of Acute Liver Failure: Preliminar Monocentric Experience
   Transplantation Proceedings, 33, 1942-1944 (2001)
3. Mitzner S, Stange J, Klammt S, Risler T, Erley CM, Bader BD, Berger ED, Lauchardt W, Peszynski P, Freytag J, Hickstein H, Loock J, Löhr JM, Liebe S, Emmrich J, Korten G, Schmidt R:
   Imrovement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial.
   Liver Transpl 2000 May;6(3):277-86
4. Stange,J.; Mitzner,S.R.; Klammt,S.; Freytag,J.; Peszynski,P.; Loock,J.; Hickstein,H.; Korten,G.; Schmidt,R.; Hentschel,J.; Schulz,M.; Lohr,M.; Liebe,S.; Schareck,W.; Hopt,U.T.
   Liver support by extracorporeal blood purification: a clinical observation
   Liver Transplantation, Vol 6, No 5 (Sept.), 2000: pp 603-613
5. Stange J, Mitzner S, Risler T, Erley CM, Lauchart W, Goehl H, Klammt S, Peszynski P, Freytag J, Hickstein H, Löhr M, Liebe S, Scharek W, Hopt UT, Schmidt R
   Molecular Adsorbent Recirculating System (MARS) - Clinical results of a new membrane based blood purification system for bioartificial liver support.
   Artif Organs 23 (1999) 319-330.
6. Loock J, Stange J, Mitzner S, Schmidt R, Schiffmann D, Weiss D, Keefer EW, Gross GW:
   Reaction of spontaneously active neuronal networks to ultrafiltrates of human blood plasma in vitro – a possible biosensor of cerebral function during metabolic diseases?
   Europ J Cell Biol 78 Suppl 49 (1999) 82
7. Majcher-Peszynska, J, Hehl EM, Wacke R, Peszynski P, Stange J, Mitzner S, Klammt S, Schmidt R, Drewelow B: Removal of Diazepam as a marker molecule for Benzodiazepine-like substances (BLS) during albumin dialysis. Clin Pharmacology 55 (1999) A26
8. Mitzner S, Stange J, Peszynski P, Klammt S, Schmidt R, Risler T:
   Extrakorporale Leberunterstützung mit dem MARS-Verfahren: Klnische Daten.
   Z Gastroenterol 37 (1999) 558
9. Mitzner S, Stange J, Klammt S, Peszynski P, Risler T, Schmidt R
   Albumin dialysis "MARS": Clinical results in hepatorenal syndrome (HRS)-treatment.
   J Hepatol 30 (1999) Suppl.1, 83
10. Loock J, Peters E, Stange J, Mitzner S, Peszinski P, Klammt S, Liebich H, Schmidt R:
    Improvement of hepatic protein synthesis as a therapeutic effect of extracorporeal detoxification in hepatic failure. Internat J Artif Org 11(1997) 500
11. Awad SS, Rich PB, Kolla S, Younger JG, Reickert CA, Downing VP, Bartlett RH.
    Characteristics of an albumin dialysate hemodiafiltration system for the clearance of unconjugated bilirubin
    ASAIO 1997; 43: M745-M749.
12. Awad SS, Sawada S, Soldes OS, Rich PB, Klein R, Alarcon WH, Bartlett RH.
    Can the clearance of tumor necrosis factor alpha and interleukin 6 be enhanced using an albumin dialysate hemodiafiltration system?
    ASAIO 1999; 45: 47-49.
13. Mitzner S, Stange J, Dillmann A, Winkler RE, Michelsen A, Knippel M, Schmidt R
    Removal of protein-bound uremic toxins by albumin dialysis: in vivo results
    Nephrol Dial Transplant 14 (1999) A201.
14. Hughes RD and Courtney JM. Dialysis/adsorption techniques for acute liver failure. In: Lee W and Williams R (eds). Acute liver failure. Cambridge, New York, Melbourne: Cambridge University Press, 1997: 278-284.
15. Kaplan AA and Epstein M. Extracorporeal blood purification in the management of patients with hepatic failure. Seminars in Nephrol 1997; 17: 576-582.
16. Kreymann B, Seige M, Schweigart U, Kopp KF, Classen M.
    Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins.
    J Hepatol 1999; 31: 1080-1085.
17. Mitzner S and Stange J: Cell-free artificial liver support- a critical review. In: Körner MM and Körfer R (eds.): Current aspects and concepts of nursing, coordinating, bridging and rehabilitation in organ transplantation. Elsevier Science B.V. Amsterdam 1995, pp 81-88.
18. Rahman TM, Hodgson HJF.
    Review article: liver support systems in acute hepatic failure.
    Aliment Pharmacol Ther 1999; 13: 1255-1272.
19. Seige M, Kreymann B, Jeschke B, Schweigart U, Kopp KF, Classen M.
    Long- term treatment of patients with acute exacerbation of chronic liver failure by albumin dialysis.
    Transplant Proc 1999; 31: 1371-1375.
20. Stange J, Ramlow W, Mitzner S, Schmidt R, Klinkmann H:
    Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins.
    Artif Org 17 (1993) 809-813.
21. Stange J and Mitzner S, Ramlow W, Gliesche T, Hickstein H, Schmidt R:
    A new procedure for the removal of protein bound drugs and toxins. ASAIO J 39 (1993) M621-M625.
22. Stange J and Mitzner S:
    A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patients blood and a bioartificial liver.
    Internat J Artif Organs 19 (1996) 677-691.
23. Mitzner S, Stange J, Korten G, Hickstein H, Emmrich J, Liebe S, Schmidt R:
    New extracorporaeal treatment of chronic hepatic failure (CHF) and hepatorenal syndrome (HRS): clinical results. Blood purif 12 (1994) 190
24. Mitzner S and Stange J:
    Treatment of acute and chronic hepatic failure with the MARS system- clinical results.
    ASAIO J 42 (1996) 12
25. Stange J and Mitzner S
    Mass transfer of albumin bound toxins through membranes-comparison between hemofiltration and the MARS-system.
    ASAIO Journal 41(1995)11
26. Stange J and Mitzner S, Klammt S, Freytag J, Look J, Hickstein H, Korten G, Schmidt R
    A hybrid membrane for the use in bioartificial liver support.
    Artif Organs 19 (1995) 1046
27. Stange J and Mitzner S
    Impact of albumin-triggered dialysis on the clinical outcome in hepatorenal syndrome.
    ASAIO J 42 (1996) 88
28. Stange J, Mitzner S, Freytag J, Klammt S, Peszynski P, Löhr M, Liebe S, Schareck W, Lauchart W, Risler T, Erley C, Hopt UT, Schmidt R
    Extracorporeal liver support therapy for patients suffering from acute on chronic hepatic failure (AOCHF) results in an improvement of Child-Turcotte-Pugh (CTP).
    J Hepatol 30 (1999) Suppl.1, 79
29. Riordan SM, Williams R
    Acute liver failure: targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failure.
    J Hepatol 2000; 32 Suppl. 1: 63-76